| Primary |
| Hypertension |
50.0% |
| Essential Hypertension |
16.7% |
| Hypertonia |
16.7% |
| Laryngeal Cancer |
16.7% |
|
| Hyperkalaemia |
33.3% |
| Asthenia |
16.7% |
| Hypersensitivity |
16.7% |
| Renal Failure Acute |
16.7% |
| Urine Output Decreased |
16.7% |
|
| Secondary |
| Hypertension |
19.0% |
| Drug Use For Unknown Indication |
9.9% |
| Diabetic Retinopathy |
8.2% |
| Atrial Fibrillation |
7.8% |
| Hyperlipidaemia |
5.8% |
| Product Used For Unknown Indication |
5.8% |
| Pyrexia |
5.6% |
| Type 2 Diabetes Mellitus |
4.8% |
| Hypotension |
4.4% |
| Bronchopneumonia |
4.3% |
| Coronary Artery Disease |
2.7% |
| Diabetes Mellitus |
2.7% |
| Hyperuricaemia |
2.7% |
| Myocardial Infarction |
2.7% |
| Sepsis |
2.7% |
| Thrombosis Prophylaxis |
2.4% |
| Oedema |
2.2% |
| Renal Failure |
2.2% |
| Diabetic Vascular Disorder |
2.0% |
| Duodenal Ulcer Haemorrhage |
2.0% |
|
| Urinary Tract Infection |
17.7% |
| Renal Failure Acute |
11.3% |
| Vomiting |
11.3% |
| Ventricular Tachycardia |
8.1% |
| Hyperkalaemia |
6.5% |
| Syncope |
6.5% |
| Abscess Limb |
4.8% |
| Traumatic Haematoma |
4.8% |
| Bronchopneumonia |
3.2% |
| Hepatorenal Syndrome |
3.2% |
| Hyponatraemia |
3.2% |
| Infection |
3.2% |
| Pulmonary Toxicity |
3.2% |
| Vertigo |
3.2% |
| Agranulocytosis |
1.6% |
| Balance Disorder |
1.6% |
| Blood Creatinine Increased |
1.6% |
| Blood Potassium Increased |
1.6% |
| Drug Exposure During Pregnancy |
1.6% |
| Fall |
1.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.1% |
| Product Used For Unknown Indication |
20.5% |
| Hypertension |
14.1% |
| Rheumatoid Arthritis |
4.3% |
| Diabetes Mellitus |
4.1% |
| Diuretic Therapy |
3.4% |
| Pain |
3.2% |
| Prophylaxis |
2.9% |
| Atrial Fibrillation |
2.4% |
| Non-small Cell Lung Cancer |
2.1% |
| Depression |
1.9% |
| Hepatic Neoplasm Malignant |
1.9% |
| Nausea |
1.8% |
| Osteoporosis |
1.7% |
| Acute Myeloid Leukaemia |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Cardiac Failure Congestive |
1.4% |
| Insomnia |
1.4% |
| Anxiety |
1.3% |
| Myocardial Ischaemia |
1.3% |
|
| Vomiting |
17.1% |
| Urinary Tract Infection |
6.5% |
| Hepatic Encephalopathy |
5.9% |
| International Normalised Ratio Increased |
5.9% |
| Pyrexia |
5.3% |
| Thrombocytopenia |
5.3% |
| Weight Decreased |
5.3% |
| Death |
4.7% |
| Platelet Count Decreased |
4.7% |
| Rash |
4.7% |
| Renal Failure Acute |
4.7% |
| Syncope |
4.1% |
| Blood Creatinine Increased |
3.5% |
| Tremor |
3.5% |
| Ventricular Tachycardia |
3.5% |
| Viral Infection |
3.5% |
| Dyspnoea |
2.9% |
| Headache |
2.9% |
| Oedema Peripheral |
2.9% |
| Pain In Extremity |
2.9% |
|
| Interacting |
| Pain |
36.8% |
| Drug Use For Unknown Indication |
21.1% |
| Hypertension |
10.5% |
| Anxiety Disorder |
5.3% |
| Essential Hypertension |
5.3% |
| Oesophageal Disorder |
5.3% |
| Product Used For Unknown Indication |
5.3% |
| Sleep Disorder |
5.3% |
| Urinary Tract Disorder |
5.3% |
|
|
